PhysioMedics is a technology company.
PhysioMedics has raised $2.0M across 1 funding round.
PhysioMedics has raised $2.0M in total across 1 funding round.
PhysioMedics has raised $2.0M in total across 1 funding round.
PhysioMedics's investors include Archangel Investors, Par Equity.
PhysioMedics is a Scottish healthcare technology company founded in 2010 that develops digital tools for managing musculoskeletal (MSK) disorders.[1][2][3] Its flagship product, PhysioWizard®, is the world's first clinically validated and CE-marked digital triage platform, enabling patients to self-assess muscle and joint issues online, receive instant summary reports, clinical advice, and personalized exercise guidance.[1][2] The company serves the healthcare industry, including global corporates, healthcare providers, and independent MSK practices, addressing inefficiencies in MSK care by improving triage, self-management, and workforce health.[1][2] With about 10 employees and $5 million in revenue, it remains at the grant stage after raising $2.07M total, focusing on digital health tech for physiotherapy and rehabilitation.[1][2]
PhysioMedics was founded in 2010 in Edinburgh, Scotland, by Kirsten Lord, a Chartered Physiotherapist, who established the company to leverage her clinical expertise in addressing MSK challenges.[3] The idea emerged from Lord's background in physiotherapy, aiming to create software that streamlines MSK disorder management amid growing demand for efficient, digital healthcare solutions.[2][3] Early traction came through developing PhysioWizard®, a pioneering tool validated clinically and CE-marked, which positioned the company as a leader in digital triage for physical therapy.[2] Based at 16 Ravelston House Park, the firm has maintained a focus on ethical patient care, workforce productivity, and partnerships across healthcare sectors.[1][2]
PhysioMedics rides the wave of digital health transformation in MSK care, where remote triage and self-management tools address rising demand from aging populations, workplace injuries, and post-pandemic telehealth adoption.[1][2] Timing aligns with regulatory approvals like CE marking, enabling scalability in Europe's healthcare market and potential US expansion, amid market forces favoring cost-effective alternatives to in-person physio.[1][2] It influences the ecosystem by partnering with providers to enhance productivity and patient outcomes, contributing to broader trends in healthtech software for preventive care and reducing healthcare burdens.[1][2]
PhysioMedics is poised for growth by expanding PhysioWizard® integrations and partnerships, potentially targeting regulatory expansions or US markets to capitalize on global MSK tech demand.[1][2] Trends like AI-enhanced triage and wearable integrations could amplify its tools, while workforce wellness initiatives sustain momentum.[2] Its influence may evolve from niche MSK innovator to key player in digital physiotherapy, reinforcing its foundational role in efficient, patient-centric healthcare.[1][3]
PhysioMedics has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in July 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2022 | $2.0M Seed | Archangel Investors, Par Equity |